{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:11:13Z","timestamp":1784121073637,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Oslo University Hospital"},{"DOI":"10.13039\/501100014232","name":"Norwegian Directorate of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014232","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heroin-assisted treatment (HAT) involves supervised dispensing of medical heroin (diacetylmorphine) for people with opioid use disorder. Clinical evidence has demonstrated the effectiveness of HAT, but little is known about the self-reported satisfaction among the patients who receive this treatment. This study presents the first empirical findings about the patients\u2019 experiences of, and satisfaction with, HAT in the Norwegian context.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Qualitative in-depth interviews with 26 patients in HAT were carried out one to two months after their enrollment. Analysis sought to identify the main benefits and challenges that the research participants experienced with this treatment. An inductive thematic analysis was conducted to identify the main areas of benefits and challenges. The benefits were weighed against the challenges in order to assess the participants\u2019 overall level of treatment satisfaction.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Analysis identified three different areas of experienced benefits and three areas of challenges of being in this treatment. It outlines how the participants\u2019 everyday lives are impacted by being in the treatment and how this, respectively, results from the treatment\u2019s medical, relational, or configurational dimensions. We found an overall high level of treatment satisfaction among the participants. The identification of experienced challenges reveals factors that reduce satisfaction and thus may hinder treatment retention and positive treatment outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study demonstrates a novel approach to qualitatively investigate patients\u2019 treatment satisfaction across different treatment dimensions. The findings have implications for clinical practice by pointing out key factors that inhibit and facilitate patients\u2019 satisfaction with HAT. The identified importance of the socio-environmental factors and relational aspect of the treatment has further implications for the provision of opioid agonist treatment in\u00a0general.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-023-00808-8","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T14:02:42Z","timestamp":1686664962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Patients\u2019 satisfaction with heroin-assisted treatment: a qualitative study"],"prefix":"10.1186","volume":"20","author":[{"given":"Rune","family":"Ellefsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Elise Cou\u00ebssurel","family":"W\u00fcsthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen Ajo","family":"Arnevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"issue":"7","key":"808_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/0706743716673966","volume":"62","author":"J Bell","year":"2017","unstructured":"Bell J, Rvd W, Strang J. Supervised injectable heroin: a clinical perspective. Can J Psychiatry. 2017;62(7):451\u20136.","journal-title":"Can J Psychiatry"},{"issue":"12","key":"808_CR2","first-page":"1","volume":"2011","author":"M Ferri","year":"2011","unstructured":"Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database Syst Rev. 2011;2011(12):1\u201348.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"808_CR3","first-page":"518","volume":"117","author":"R Smart","year":"2021","unstructured":"Smart R, Reuter P. Does heroin-assisted treatment reduce crime? Rev Randomized-controll Trials Addict. 2021;117(3):518\u201331.","journal-title":"Rev Randomized-controll Trials Addict"},{"issue":"5","key":"808_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","volume":"73","author":"E Oviedo-Joekes","year":"2016","unstructured":"Oviedo-Joekes E, Guh D, Brissette S, Marchand K, MacDonald S, Lock K, et al. Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial. JAMA Psychiat. 2016;73(5):447\u201355.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"808_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","volume":"207","author":"J Strang","year":"2015","unstructured":"Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, et al. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. Br J Psychiatry. 2015;207(1):5\u201314.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"808_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000525694","volume":"28","author":"I Skeie","year":"2022","unstructured":"Skeie I, Clausen T, Hjems\u00e6ter AJ, Landheim AS, Monsbakken B, Thoresen M, et al. Mortality, causes of death, and predictors of death among patients on and off opioid agonist treatment: results from a 19-year cohort study. Eur Addict Res. 2022;28(5):358\u201367.","journal-title":"Eur Addict Res"},{"key":"808_CR7","first-page":"2022","volume-title":"Statusrapport 2021: Siste \u00e5r med gamle LAR-retningslinjer [Status report 2021: Last year of the old OAT guidelines]","author":"AB Bech","year":"2022","unstructured":"Bech AB, Bukten A, Lobmaier P, Skeie I, Lillevold PH, Clausen T. Statusrapport 2021: Siste \u00e5r med gamle LAR-retningslinjer [Status report 2021: Last year of the old OAT guidelines]. Oslo: Norwegian Centre for Addiction Research; 2022. p. 2022."},{"key":"808_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13643-021-01764-9","volume":"10","author":"J Klimas","year":"2021","unstructured":"Klimas J, Hamilton MA, Gorfinkel L, Adam A, Cullen W, Wood E. Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials. Syst Rev. 2021;10:216. https:\/\/doi.org\/10.1186\/s13643-021-01764-9.","journal-title":"Syst Rev"},{"issue":"3","key":"808_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/00952991003736371","volume":"36","author":"SM Kelly","year":"2010","unstructured":"Kelly SM, O\u2019Grady KE, Brown BS, Mitchell SG, Schwartz RP. The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse. 2010;36(3):150\u20134.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"808_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.drugalcdep.2005.03.021","volume":"79","author":"CJ de los P\u00e9rez","year":"2005","unstructured":"de los P\u00e9rez CJ, Trujols J, Valderrama JC, Valero S, Puig T. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment. Drug Alcohol Depend. 2005;79(3):405\u201312.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"808_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/09687637.2014.981508","volume":"22","author":"W Vanderplasschen","year":"2014","unstructured":"Vanderplasschen W, Naert J, Vander Laenen F, De Maeyer J. Treatment satisfaction and quality of support in outpatient substitution treatment: opiate users\u2019 experiences and perspectives. Drugs Educ Prev Policy. 2014;22(3):272\u2013800.","journal-title":"Drugs Educ Prev Policy"},{"issue":"32","key":"808_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta6320","volume":"6","author":"R Crow","year":"2002","unstructured":"Crow R, Gage H, Hampson S, Hart J, Kimber A, Storey L, et al. The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature. Health Technol Assess. 2002;6(32):1\u2013244.","journal-title":"Health Technol Assess"},{"issue":"7","key":"808_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1176\/appi.ps.55.7.767","volume":"55","author":"Y-I Hser","year":"2004","unstructured":"Hser Y-I, Evans E, Huang D, Anglin DM. Relationship between drug treatment services, retention, and outcomes. Psychiatr Serv. 2004;55(7):767\u201374.","journal-title":"Psychiatr Serv"},{"issue":"5","key":"808_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/09595230701499118","volume":"26","author":"LR Gjersing","year":"2007","unstructured":"Gjersing LR, Butler T, Caplehorn JRM, Belcher JM, Matthews R. Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff. Drug Alcohol Rev. 2007;26(5):501\u20138.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"808_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1472-6963-10-194","volume":"10","author":"L Gjersing","year":"2010","unstructured":"Gjersing L, Waal H, Caplehorn JR, Gossop M, Clausen T. Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment. BMC Health Serv Res. 2010;10(1):194.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"808_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1447-0349.2011.00795.x","volume":"21","author":"D Deering","year":"2012","unstructured":"Deering D, Horn J, Frampton CMA. Clients\u2019 perceptions of opioid substitution treatment: an input to improving the quality of treatment. Int J Ment Health Nurs. 2012;21(4):330\u20139.","journal-title":"Int J Ment Health Nurs"},{"issue":"2","key":"808_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/713660101","volume":"7","author":"R Lilly","year":"2000","unstructured":"Lilly R, Quirk A, Rhodes T, Stimson GV. Sociality in methadone treatment: understanding methadone treatment and service delivery as a social process. Drugs Educ Prev Policy. 2000;7(2):163\u201378.","journal-title":"Drugs Educ Prev Policy"},{"key":"808_CR18","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2147\/PPA.S164181","volume":"12","author":"S Alcaraz","year":"2018","unstructured":"Alcaraz S, Viladrich C, Trujols J, Si\u00f1ol N, et al. Heroin-dependent patient satisfaction with methadone as a medication influences satisfaction with basic interventions delivered by staff to implement methadone maintenance treatment. Patient Prefer Adher. 2018;12:1203\u20132118.","journal-title":"Patient Prefer Adher"},{"issue":"Suppl. 2","key":"808_CR19","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/S0924-977X(10)70001-8","volume":"20","author":"P Blanken","year":"2010","unstructured":"Blanken P, van den Brink W, Hendriks VM, Huijsman IA, Klous MG, Rook EJ, et al. Heroin-assisted treatment in the Netherlands: history, findings, and international context. Eur Neuropsychopharmacol. 2010;20(Suppl. 2):S105\u201358.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"808_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/16066359909004387","volume":"7","author":"R Lilly","year":"1999","unstructured":"Lilly R, Quirk A, Rhodes T, Stimson GV. Juggling multiple roles: staff and client perceptions of keyworker roles and the constraints on delivering counselling and support services in methadone treatment. Addict Res. 1999;7(4):267\u201389.","journal-title":"Addict Res"},{"key":"808_CR21","doi-asserted-by":"publisher","first-page":"108512","DOI":"10.1016\/j.jsat.2021.108512","volume":"132","author":"K Marchand","year":"2022","unstructured":"Marchand K, Palis H, Guh D, Lock K, MacDonald S, Brissette S, et al. A multi-methods and longitudinal study of patients\u2019 perceptions in injectable opioid agonist treatment: implications for advancing patient-centered methodologies in substance use research. J Subst Abuse Treat. 2022;132:108512.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"808_CR22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1080\/10826080802483936","volume":"44","author":"S Anstice","year":"2009","unstructured":"Anstice S, Strike CJ, Brands B. Supervised methadone consumption: client issues and stigma. Subst Use Misuse. 2009;44(6):794\u2013808.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"808_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1465-3362.2008.00015.x","volume":"28","author":"N Romo","year":"2009","unstructured":"Romo N, Poo M, Ballesta R. From illegal poison to legal medicine: a qualitative research in a heroin-prescription trial in Spain. Drug Alcohol Rev. 2009;28(2):186\u201395.","journal-title":"Drug Alcohol Rev"},{"issue":"21","key":"808_CR24","first-page":"1","volume":"9","author":"E Oviedo-Joekes","year":"2014","unstructured":"Oviedo-Joekes E, Marchand K, Lock K, Chettiar J, Marsh DC, Brissette S, et al. A chance to stop and breathe: participants\u2019 experiences in the North American Opiate medication initiative clinical trial. Addict Sci Clin Pract. 2014;9(21):1\u201310.","journal-title":"Addict Sci Clin Pract"},{"issue":"8\u201310","key":"808_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1081\/JA-120004176","volume":"37","author":"J Bell","year":"2002","unstructured":"Bell J, Dru A, Fischer B, Levit S, Sarfraz MA. Substitution therapy for heroin addiction. Subst Use Misuse. 2002;37(8\u201310):1149\u201378.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"808_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s11524-007-9198-y","volume":"84","author":"B Fischer","year":"2007","unstructured":"Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter MT, et al. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health. 2007;84(4):552\u201362.","journal-title":"J Urban Health"},{"issue":"27","key":"808_CR27","first-page":"1","volume":"14","author":"S Boyd","year":"2017","unstructured":"Boyd S, Murray D, et al. Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver. Harm Reduct J. 2017;14(27):1\u201314.","journal-title":"Harm Reduct J"},{"key":"808_CR28","unstructured":"Johansen KS. Heroinbehandling i Danmark: en unders\u00f8gelse av brugere av behandling [Heroin-treatment in Denmark: an investigation of the users and treatment]. Glostrup: KABS Viden; 2013:221-2. Accessed 25 May 2023 from https:\/\/viden.kabs.dk\/wp-content\/uploads\/2018\/05\/kabs_heroinbehandling-dk_elektronisk_5.pdf"},{"issue":"6","key":"808_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/16066359809004369","volume":"6","author":"S Wright","year":"1998","unstructured":"Wright S, Klee H, Reid P. Interviewing Illicit drug users: observations from the field. Addict Res. 1998;6(6):517\u201335.","journal-title":"Addict Res"},{"issue":"3","key":"808_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","volume":"18","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qual Res Psychol. 2021;18(3):328\u201352.","journal-title":"Qual Res Psychol"},{"issue":"2","key":"808_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1172\/JCI33946","volume":"118","author":"JN Cleck","year":"2008","unstructured":"Cleck JN, Blendy JA. Making a bad thing worse: adverse effects of stress on drug addiction. J Clin Investig. 2008;118(2):454\u201361.","journal-title":"J Clin Investig"},{"issue":"3","key":"808_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1360-0443.2004.00935.x","volume":"100","author":"PS Meier","year":"2005","unstructured":"Meier PS, Barrowclough C, Donmall MC. The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction. 2005;100(3):304\u201316.","journal-title":"Addiction"},{"issue":"3","key":"808_CR33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/symb.291","volume":"40","author":"A Skatvedt","year":"2017","unstructured":"Skatvedt A. The importance of \u201cempty gestures\u201d in recovery: being human together. Symb Interact. 2017;40(3):396\u2013413.","journal-title":"Symb Interact"},{"issue":"6","key":"808_CR34","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/1049732311432718","volume":"22","author":"J Harris","year":"2012","unstructured":"Harris J, Elrath K. Methadone as social control: institutionalized stigma and the prospect of recovery. Qual Health Res. 2012;22(6):810\u201324.","journal-title":"Qual Health Res"},{"issue":"2","key":"808_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/09687637.2013.848841","volume":"21","author":"G Gilchrist","year":"2014","unstructured":"Gilchrist G, Moskalewicz J, Nutt R, Love J, Germeni E, Valkova I, et al. Understanding access to drug and alcohol treatment services in Europe: a multi-country service users\u2019 perspective. Drugs Educ Prev Policy. 2014;21(2):120\u201330.","journal-title":"Drugs Educ Prev Policy"},{"issue":"102930","key":"808_CR36","first-page":"1","volume":"85","author":"S Mayer","year":"2020","unstructured":"Mayer S, Fowler A, Brohman I, Fairbairn N, Boyd J, Kerr T, et al. Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: a qualitative study of patient experiences in Vancouver. Canada Int J Drug Policy. 2020;85(102930):1\u20139.","journal-title":"Canada Int J Drug Policy"},{"issue":"6","key":"808_CR37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2850.2011.01810.x","volume":"19","author":"I Demaret","year":"2012","unstructured":"Demaret I, Lema\u00cetre A, Ansseau M. Staff concerns in heroin-assisted treatment centres. J Psychiatr Ment Health Nurs. 2012;19(6):563\u20137.","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"2","key":"808_CR38","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/ijerph20021526","volume":"20","author":"VR Carlisle","year":"2023","unstructured":"Carlisle VR, Maynard OM, Bagnall D, Hickman M, Shorrock J, Thomas K, et al. Should I stay or should I Go? A qualitative exploration of stigma and other factors influencing opioid agonist treatment journeys. Int J Environ Res Public Health. 2023;20(2):1526.","journal-title":"Int J Environ Res Public Health"},{"key":"808_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/qhw.v9.23698","volume":"9","author":"E Jozaghi","year":"2014","unstructured":"Jozaghi E. \u2018\u201cSALOME gave my dignity back\u201d\u2019: the role of randomized heroin trials in transforming lives in the downtown eastside of Vancouver, Canada. Int J Qual Stud Health Well Being. 2014;9:1\u20139.","journal-title":"Int J Qual Stud Health Well Being"},{"key":"808_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.apnr.2018.12.003","volume":"45","author":"J McCall","year":"2019","unstructured":"McCall J, Phillips JC, Estafan A, Caine V. Exploring the experiences of staff working at an opiate assisted treatment clinic: an interpretive descriptive study. Appl Nurs Res. 2019;45:45\u201351.","journal-title":"Appl Nurs Res"},{"issue":"7","key":"808_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/0706743716673966","volume":"62","author":"J Bell","year":"2017","unstructured":"Bell J, van der Waal R, Strang J. Supervised injectable heroin: a clinical perspective. Can J Psychiatry. 2017;62(7):451\u20136.","journal-title":"Can J Psychiatry"},{"issue":"2","key":"808_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11469-018-9957-x","volume":"18","author":"RR Lago","year":"2020","unstructured":"Lago RR, B\u00f3gus CM, Peter E. An exploration of the relational autonomy of people with substance use disorders: constraints and limitations. Int J Ment Heal Addict. 2020;18(2):277\u201392.","journal-title":"Int J Ment Heal Addict"},{"issue":"1","key":"808_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2975\/31.1.2007.23.31","volume":"31","author":"L Davidson","year":"2007","unstructured":"Davidson L, Tondora J, O\u2019Connell MJ, Kirk T, Rockholz P, Evans AC. Creating a recovery-oriented system of behavioral health care: moving from concept to reality. Psychiatr Rehabil J. 2007;31(1):23\u201331.","journal-title":"Psychiatr Rehabil J"},{"issue":"S1","key":"808_CR44","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1002\/mpr.244","volume":"17","author":"N Scherbaum","year":"2008","unstructured":"Scherbaum N, Specka M. Factors influencing the course of opiate addiction. Int J Methods Psychiatr Res. 2008;17(S1):S39\u201344.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"1","key":"808_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11205-008-9315-7","volume":"90","author":"J De Maeyer","year":"2008","unstructured":"De Maeyer J, Vanderplasschen W, Broekaert E. Exploratory study on drug users\u2019 perspectives on quality of life: more than health-related quality of life? Soc Indic Res. 2008;90(1):107\u201326.","journal-title":"Soc Indic Res"},{"key":"808_CR46","doi-asserted-by":"crossref","unstructured":"Riley F, Harris M, Ahmed D, Moore H, Poulter L, Towl G, et al. \u2018I feel like I found myself again\u2019 \u2013 rethinking \u2018recovery\u2019 in a qualitative exploration of Heroin Assisted Treatment (HAT) service users\u2019 experiences. BMC Harm Reduct J. 2022.","DOI":"10.21203\/rs.3.rs-2310440\/v1"},{"key":"808_CR47","doi-asserted-by":"publisher","first-page":"104025","DOI":"10.1016\/j.drugpo.2023.104025","volume":"116","author":"HL Poulter","year":"2023","unstructured":"Poulter HL, Walker T, Ahmed D, Moore HJ, Riley F, Towl G, Harris M. More than just \u2018free heroin\u2019: caring whilst navigating constraint in the delivery of diamorphine assisted treatment. Int J Drug Polic. 2023;116:104025. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104025.","journal-title":"Int J Drug Polic"},{"key":"808_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00785-y","author":"F Riley","year":"2023","unstructured":"Riley F, Harris M, Poulter HL, Moore HJ, Ahmed D, Towl G, Walker T. \u2018This is hardcore\u2019: a qualitative study exploring service users\u2019 experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England. Harm Reduct J. 2023. https:\/\/doi.org\/10.1186\/s12954-023-00785-y.","journal-title":"Harm Reduct J"},{"issue":"1","key":"808_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13011-020-0253-y","volume":"15","author":"K Marchand","year":"2020","unstructured":"Marchand K, Foreman J, MacDonald S, Harrison S, Schechter MT, Oviedo-Joekes E. Building healthcare provider relationships for patient-centered care: a qualitative study of the experiences of people receiving injectable opioid agonist treatment. Subst Abuse Treat Prev Polic. 2020;15(1):7.","journal-title":"Subst Abuse Treat Prev Polic"},{"issue":"108984","key":"808_CR50","first-page":"1","volume":"227","author":"MLF Martins","year":"2021","unstructured":"Martins MLF, Wilthagen EA, Oviedo-Joekes E, Beijnen JH, de Grave N, Uchtenhagen A, et al. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: a scoping review. Drug Alcohol Depend. 2021;227(108984):1\u201315.","journal-title":"Drug Alcohol Depend"},{"key":"808_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109869","author":"R McNair","year":"2023","unstructured":"McNair R, Monaghan M, Montgomery P. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: a context-focused systematic review. Drug Alcohol Depend. 2023. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109869.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"808_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000141646","volume":"14","author":"D Zador","year":"2008","unstructured":"Zador D, Lintzeris N, van der Waal R, Miller P, Metrebian N, Strang J. The fine line between harm reduction and harm production \u2013 development of a clinical policy on femoral (Groin) injecting. Eur Addict Res. 2008;14(4):213\u20138.","journal-title":"Eur Addict Res"},{"key":"808_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103548","author":"M Meyer","year":"2022","unstructured":"Meyer M, Strasser J, K\u00f6ck P, Walter M, Vogel M, D\u00fcrsteler KM. Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic - is an update of legal restrictions warranted? Int J Drug Polic. 2022. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103548.","journal-title":"Int J Drug Polic"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00808-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00808-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00808-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T15:05:17Z","timestamp":1686668717000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00808-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00808-8","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the Regional Ethical Committee (195733) as well as the local Data Protection Officers in Bergen Health Trust (3061\u20133061) and Oslo University Hospital (20\/27594). All data were handled and stored in line with regulations for health research and sensitive personal data. Written informed consent was obtained from the participants prior to the study procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}